VWF and von Hippel-Lindau disease: The detailed indications include choroidal neovascularization, intravascular thrombus, acute coronary syndrome/coronary artery disease, von Willebrand factor related disorders, von Hippel–Lindau syndrome (VHL), angiomas, acute myeloid leukemia, renal cell carcinoma, non-small cell lung cancer, and thrombotic thrombocytopenic purpura.